Separately, Dawson James reiterated a neutral rating on shares of IMAC in a research note on Tuesday, January 14th.
Shares of IMAC stock traded down $0.04 during midday trading on Monday, reaching $0.97. 18,466 shares of the company were exchanged, compared to its average volume of 201,893. IMAC has a 12 month low of $0.93 and a 12 month high of $7.20. The company’s 50 day moving average price is $1.32 and its two-hundred day moving average price is $2.61. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.78.
IMAC Holdings, Inc operates a chain of integrated medicine and chiropractic regeneration centers. The company's outpatient clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions.
Read More: Trading Ex-Dividend Strategy
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.